FDA Panel Urges More Testing for Diabetes Drugs

July 28, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

NEW YORK (Associated Press) - Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.

Twitter
LinkedIn
Facebook
Email
Print

FDA Approvals Regulatory

Food and Drug Administration (FDA)